Technology | March 22, 2011

Intelligent Cardiac Structured Reporting Featured at ACC 2011

March 22, 2011 - Further enhancing its cardiovascular reporting capabilities, Fujifilm Medical Systems Inc. added its Intelligent Structured Reporting (ISR) technology, an advanced software decision support system. ISR will be featured along with the complete lineup of Synapse Cardiovascular products at the American College of Cardiology (ACC) 2011 Annual Scientific Session and Expo, April 2–5, in New Orleans. Fujifilm’s booth is 2001.

ISR is the latest addition to the Synapse family solutions to enhance clinical workflow and increase diagnostic certainty. The software aids efficiency by enabling cardiologists to read more exams in less time. It does this by incorporating an advanced tool set that directly ties echo measurement data and clinical statements to a comparative knowledge base. This helps improve the reading accuracy and report consistency when interpreting echocardiograms.

Advanced capabilities of ISR include the ability to monitor input echo measurements in real-time, warn the user of inconsistencies and automatically complete an echocardiography report based on absolute and inferred data. The application also suggests further areas of evaluation, based on clinical findings, and outlines a treatment consideration for the patient.

ISR brings a new clinical concept to echo reporting using the Agile Computing Theory. This technology makes frequent, real-time updates to Synapse Cardiovascular to ensure that the cardiologist and sonographers are equipped with the latest cardiovascular information. This data is standards-based and all suggestions provided by the system are directly traceable to a clinical source. The database includes thousands of peer-reviewed clinical papers so cardiologists have the ability to prove statements and perform further research.

Fujifilm will also be featuring its full range of informatics products, including Synapse 3D and Synapse Mobility, at the 2011 ACC.

For more information: www.fujimed.com

Related Content

ScImage and Invia Partnership Announced
News | Cardiac PACS| September 19, 2017
ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature
Technology | Cardiovascular Ultrasound| September 06, 2017
The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
GE’s blood speckle imaging (BSI) software shows the flow of blood cells’ trajectories. It is a form of blood vector flow imaging.

GE’s blood speckle imaging (BSI) software offers the ability to view a graphical representation of the blood cells’ trajectories.

News | Cardiovascular Ultrasound| September 01, 2017
Cardiologists are constantly on the lookout for new methods to examine the heart using new imaging technology advance
Sponsored Content | Videos | Cardiovascular Ultrasound| August 30, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Overlay Init